# KLA Corp: financial statements, quarterly

KLAC · Nasdaq · CIK 319201 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/klac.md) · [Financials](/companies/klac/financials.md) · [Filings](/companies/klac/filings.md) · [Insiders](/companies/klac/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/klac/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,397](/filings/0000319201-24-000027.md) | [2,487](/filings/0000319201-25-000006.md) | [2,360](/filings/0000319201-25-000012.md) | [2,569 d](/filings/0000319201-26-000027.md) | [2,842](/filings/0000319201-25-000034.md) | [3,077](/filings/0000319201-26-000008.md) | [3,063](/filings/0000319201-26-000016.md) | [3,175 d](/filings/0000319201-26-000027.md) | [3,210](/filings/0000319201-25-000034.md) | [3,297](/filings/0000319201-26-000008.md) | [3,415](/filings/0000319201-26-000016.md) | [3,658 d](/filings/0000319201-26-000027.md) |
| Cost of revenue | $m | [947](/filings/0000319201-24-000027.md) | [977](/filings/0000319201-25-000006.md) | [994](/filings/0000319201-25-000012.md) | [1,011 d](/filings/0000319201-26-000027.md) | [1,147](/filings/0000319201-25-000034.md) | [1,221](/filings/0000319201-26-000008.md) | [1,176](/filings/0000319201-26-000016.md) | [1,207 d](/filings/0000319201-26-000027.md) | [1,243](/filings/0000319201-25-000034.md) | [1,271](/filings/0000319201-26-000008.md) | [1,328](/filings/0000319201-26-000016.md) | [1,413 d](/filings/0000319201-26-000027.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [311](/filings/0000319201-24-000027.md) | [320](/filings/0000319201-25-000006.md) | [322](/filings/0000319201-25-000012.md) | [326 d](/filings/0000319201-26-000027.md) | [323](/filings/0000319201-25-000034.md) | [346](/filings/0000319201-26-000008.md) | [338](/filings/0000319201-26-000016.md) | [353 d](/filings/0000319201-26-000027.md) | [360](/filings/0000319201-25-000034.md) | [384](/filings/0000319201-26-000008.md) | [389](/filings/0000319201-26-000016.md) | [399 d](/filings/0000319201-26-000027.md) |
| Selling, general and administrative | $m | [240](/filings/0000319201-24-000027.md) | [237](/filings/0000319201-25-000006.md) | [238](/filings/0000319201-25-000012.md) | [255 d](/filings/0000319201-26-000027.md) | [251](/filings/0000319201-25-000034.md) | [267](/filings/0000319201-26-000008.md) | [249](/filings/0000319201-26-000016.md) | [263 d](/filings/0000319201-26-000027.md) | [269](/filings/0000319201-25-000034.md) | [280](/filings/0000319201-26-000008.md) | [291](/filings/0000319201-26-000016.md) | [291 d](/filings/0000319201-26-000027.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [74.2](/filings/0000319201-23-000039.md) | [74.2](/filings/0000319201-24-000006.md) | [80.0](/filings/0000319201-24-000012.md) | [82.8 d](/filings/0000319201-26-000027.md) | [82.2](/filings/0000319201-25-000034.md) | [75.0](/filings/0000319201-26-000008.md) | [71.9](/filings/0000319201-26-000016.md) | [73.1 d](/filings/0000319201-26-000027.md) | [71.1](/filings/0000319201-25-000034.md) | [69.7](/filings/0000319201-26-000008.md) | [70.4](/filings/0000319201-26-000016.md) | [73.3 d](/filings/0000319201-26-000027.md) |
| Income tax | $m | [110](/filings/0000319201-24-000027.md) | [109](/filings/0000319201-25-000006.md) | [100](/filings/0000319201-25-000012.md) | [109 d](/filings/0000319201-26-000027.md) | [133](/filings/0000319201-25-000034.md) | [148](/filings/0000319201-26-000008.md) | [176](/filings/0000319201-26-000016.md) | [126 d](/filings/0000319201-26-000027.md) | [188](/filings/0000319201-25-000034.md) | [185](/filings/0000319201-26-000008.md) | [216](/filings/0000319201-26-000016.md) | [186 d](/filings/0000319201-26-000027.md) |
| Net income | $m | [741](/filings/0000319201-25-000012.md) | [583](/filings/0000319201-25-000012.md) | [602](/filings/0000319201-25-000012.md) | [836 d](/filings/0000319201-26-000027.md) | [946](/filings/0000319201-26-000016.md) | [825](/filings/0000319201-26-000016.md) | [1,088](/filings/0000319201-26-000016.md) | [1,203 d](/filings/0000319201-26-000027.md) | [1,121](/filings/0000319201-26-000016.md) | [1,146](/filings/0000319201-26-000016.md) | [1,201](/filings/0000319201-26-000016.md) | [1,363 d](/filings/0000319201-26-000027.md) |
| Diluted EPS | $ per share | [5.41](/filings/0000319201-24-000027.md) | [4.28](/filings/0000319201-25-000006.md) | [4.43](/filings/0000319201-25-000012.md) | not reported | [7.01](/filings/0000319201-25-000034.md) | [6.16](/filings/0000319201-26-000008.md) | [8.16](/filings/0000319201-26-000016.md) | not reported | [8.47](/filings/0000319201-25-000034.md) | [8.68](/filings/0000319201-26-000008.md) | [9.12](/filings/0000319201-26-000016.md) | not reported |
| Basic EPS | $ per share | [5.43](/filings/0000319201-24-000027.md) | [4.30](/filings/0000319201-25-000006.md) | [4.46](/filings/0000319201-25-000012.md) | not reported | [7.05](/filings/0000319201-25-000034.md) | [6.18](/filings/0000319201-26-000008.md) | [8.21](/filings/0000319201-26-000016.md) | not reported | [8.51](/filings/0000319201-25-000034.md) | [8.73](/filings/0000319201-26-000008.md) | [9.17](/filings/0000319201-26-000016.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.7](/filings/0000319201-23-000039.md) | [1.7](/filings/0000319201-24-000006.md) | [1.8](/filings/0000319201-24-000012.md) | [2.0](/filings/0000319201-25-000024.md) | [2.0](/filings/0000319201-24-000027.md) | [1.8](/filings/0000319201-25-000006.md) | [1.9](/filings/0000319201-25-000012.md) | [2.1](/filings/0000319201-26-000027.md) | [1.9](/filings/0000319201-25-000034.md) | [2.5](/filings/0000319201-26-000008.md) | [1.8](/filings/0000319201-26-000016.md) | [1.6](/filings/0000319201-26-000027.md) |
| Current assets | $bn | [8.4](/filings/0000319201-23-000039.md) | [8.7](/filings/0000319201-24-000006.md) | [9.5](/filings/0000319201-24-000012.md) | [10.0](/filings/0000319201-25-000024.md) | [10.2](/filings/0000319201-24-000027.md) | [9.8](/filings/0000319201-25-000006.md) | [9.9](/filings/0000319201-25-000012.md) | [10.7](/filings/0000319201-26-000027.md) | [10.9](/filings/0000319201-25-000034.md) | [11.3](/filings/0000319201-26-000008.md) | [11.4](/filings/0000319201-26-000016.md) | [12.4](/filings/0000319201-26-000027.md) |
| Total assets | $bn | [14.1](/filings/0000319201-23-000039.md) | [14.3](/filings/0000319201-24-000006.md) | [15.0](/filings/0000319201-24-000012.md) | [15.4](/filings/0000319201-25-000024.md) | [15.7](/filings/0000319201-24-000027.md) | [15.0](/filings/0000319201-25-000006.md) | [15.2](/filings/0000319201-25-000012.md) | [16.1](/filings/0000319201-26-000027.md) | [16.3](/filings/0000319201-25-000034.md) | [16.7](/filings/0000319201-26-000008.md) | [16.9](/filings/0000319201-26-000016.md) | [18.0](/filings/0000319201-26-000027.md) |
| Current liabilities | $bn | [3.8](/filings/0000319201-23-000039.md) | [4.6](/filings/0000319201-24-000006.md) | [4.5](/filings/0000319201-24-000012.md) | [4.7](/filings/0000319201-25-000024.md) | [4.8](/filings/0000319201-24-000027.md) | [4.1](/filings/0000319201-25-000006.md) | [3.9](/filings/0000319201-25-000012.md) | [4.1](/filings/0000319201-26-000027.md) | [4.0](/filings/0000319201-25-000034.md) | [4.0](/filings/0000319201-26-000008.md) | [3.8](/filings/0000319201-26-000016.md) | [4.3](/filings/0000319201-26-000027.md) |
| Total liabilities | $bn | [11.1](/filings/0000319201-23-000039.md) | [11.2](/filings/0000319201-24-000006.md) | [11.9](/filings/0000319201-24-000012.md) | [12.1](/filings/0000319201-25-000024.md) | [12.1](/filings/0000319201-24-000027.md) | [11.4](/filings/0000319201-25-000006.md) | [11.2](/filings/0000319201-25-000012.md) | [11.4](/filings/0000319201-26-000027.md) | [11.3](/filings/0000319201-25-000034.md) | [11.3](/filings/0000319201-26-000008.md) | [11.0](/filings/0000319201-26-000016.md) | [11.6](/filings/0000319201-26-000027.md) |
| Long-term debt | $bn | [5.9](/filings/0000319201-23-000039.md) | [5.1](/filings/0000319201-24-000006.md) | [5.9](/filings/0000319201-24-000012.md) | [5.9](/filings/0000319201-25-000024.md) | [5.9](/filings/0000319201-24-000027.md) | [5.9](/filings/0000319201-25-000006.md) | [5.9](/filings/0000319201-25-000012.md) | [5.9](/filings/0000319201-26-000027.md) | [5.9](/filings/0000319201-25-000034.md) | [5.9](/filings/0000319201-26-000008.md) | [5.9](/filings/0000319201-26-000016.md) | [5.9](/filings/0000319201-26-000027.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | [0.7](/filings/0000319201-25-000024.md) | [0.7](/filings/0000319201-24-000027.md) | [0.0](/filings/0000319201-25-000006.md) | [0.0](/filings/0000319201-25-000012.md) | [0.0](/filings/0000319201-25-000024.md) | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | [0.7](/filings/0000319201-24-000006.md) | [0.7](/filings/0000319201-24-000012.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [3.0](/filings/0000319201-25-000012.md) | [3.0](/filings/0000319201-24-000006.md) | [3.1](/filings/0000319201-24-000012.md) | [3.4](/filings/0000319201-26-000016.md) | [3.6](/filings/0000319201-26-000016.md) | [3.6](/filings/0000319201-26-000016.md) | [4.0](/filings/0000319201-26-000016.md) | [4.7](/filings/0000319201-26-000027.md) | [5.0](/filings/0000319201-26-000016.md) | [5.5](/filings/0000319201-26-000016.md) | [5.8](/filings/0000319201-26-000016.md) | [6.3](/filings/0000319201-26-000027.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [884](/filings/0000319201-24-000027.md) | [622 d](/filings/0000319201-25-000006.md) | [910 d](/filings/0000319201-25-000012.md) | [893 d](/filings/0000319201-26-000027.md) | [995](/filings/0000319201-25-000034.md) | [850 d](/filings/0000319201-26-000008.md) | [1,072 d](/filings/0000319201-26-000016.md) | [1,165 d](/filings/0000319201-26-000027.md) | [1,162](/filings/0000319201-25-000034.md) | [1,368 d](/filings/0000319201-26-000008.md) | [707 d](/filings/0000319201-26-000016.md) | [906 d](/filings/0000319201-26-000027.md) |
| Capital expenditure | $m | [68.0](/filings/0000319201-24-000027.md) | [76.8 d](/filings/0000319201-25-000006.md) | [71.8 d](/filings/0000319201-25-000012.md) | [60.7 d](/filings/0000319201-26-000027.md) | [60.4](/filings/0000319201-25-000034.md) | [92.3 d](/filings/0000319201-26-000008.md) | [82.1 d](/filings/0000319201-26-000016.md) | [100 d](/filings/0000319201-26-000027.md) | [95.9](/filings/0000319201-25-000034.md) | [106 d](/filings/0000319201-26-000008.md) | [85.2 d](/filings/0000319201-26-000016.md) | [89.3 d](/filings/0000319201-26-000027.md) |
| Dividends paid | $m | [182](/filings/0000319201-24-000027.md) | [197](/filings/0000319201-24-000006.md) | [197](/filings/0000319201-24-000012.md) | [198 d](/filings/0000319201-26-000027.md) | [198](/filings/0000319201-25-000034.md) | [227 d](/filings/0000319201-26-000008.md) | [226 d](/filings/0000319201-26-000016.md) | [254 d](/filings/0000319201-26-000027.md) | [254](/filings/0000319201-25-000034.md) | [250 d](/filings/0000319201-26-000008.md) | [249 d](/filings/0000319201-26-000016.md) | [305 d](/filings/0000319201-26-000027.md) |
| Share repurchases | $m | [455](/filings/0000319201-24-000027.md) | [438 d](/filings/0000319201-25-000006.md) | [372 d](/filings/0000319201-25-000012.md) | [470 d](/filings/0000319201-26-000027.md) | [567](/filings/0000319201-25-000034.md) | [650 d](/filings/0000319201-26-000008.md) | [507 d](/filings/0000319201-26-000016.md) | [426 d](/filings/0000319201-26-000027.md) | [545](/filings/0000319201-25-000034.md) | [548 d](/filings/0000319201-26-000008.md) | [626 d](/filings/0000319201-26-000016.md) | [571 d](/filings/0000319201-26-000027.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [143](/filings/0000319201-23-000039.md) | [142](/filings/0000319201-24-000006.md) | [139](/filings/0000319201-24-000012.md) | [137](/filings/0000319201-24-000027.md) | [136](/filings/0000319201-25-000006.md) | [136](/filings/0000319201-25-000012.md) | [135](/filings/0000319201-25-000034.md) | [134](/filings/0000319201-26-000008.md) | [133](/filings/0000319201-26-000016.md) | [132](/filings/0000319201-25-000034.md) | [132](/filings/0000319201-26-000008.md) | [132](/filings/0000319201-26-000016.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,306,546,783 at 2026-08-03, from the cover of the [10-K filed 2026-08-06](/filings/0000319201-26-000027.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.